Skip Navigation

JNCI Journal of the National Cancer Institute 1999 91(12):1002-1003; doi:10.1093/jnci/91.12.1002
© 1999 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 91, No. 12, 1002-1003, June 16, 1999
© 1999 Oxford University Press

NEWS

Awards, Appointments, Announcements

The American Society of Clinical Oncology gave John R. Durant, M.D., its Special Recognition Award in honor of his "noteworthy" 4-year tenure as ASCO's first executive vice president. Durant, who has led the organization since 1995, announced last year that he would retire as soon as a replacement could be found.



View larger version (135K):
[in this window]
[in a new window]
  		Dr. John R. Durant

 
Durant is credited with transforming ASCO into a self-managed society. For 31 years, it had been managed by an outside company and until 1995 had only three employees. Now, ASCO's budget has doubled, it has . . . [Full Text of this Article]

ASCI Award to Klausner

Editorial Awards

Robb Named Chair

NCI Appointment

New ASCO President

Circle of Life

ONS Guidelines

Prevention Fellowships


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?